Trial Profile
Trial Investigating the Hypoglycaemic Response to Single Doses of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Novo Nordisk
- 01 Nov 2009 Results published in Diabetologia.
- 13 Oct 2008 New trial record.